Identification and design of a novel series of MGAT2 inhibitors

[Acyl CoA]monoacylglycerol acyltransferase 2 (MGAT2) is of interest as a target for therapeutic treatment of diabetes, obesity and other diseases which together constitute the metabolic syndrome. In this Letter we report our discovery and optimisation of a novel series of MGAT2 inhibitors. The development of the SAR of the series and a detailed discussion around some key parameters monitored and addressed during the lead generation phase will be given. The in vivo results from an oral lipid tolerance test (OLTT) using the MGAT2 inhibitor (S)-10, shows a significant reduction (68% inhibition relative to na?ve, p <0.01) in plasma triacylglycerol (TAG) concentration.     

Complementary Aluminum Nanopatch/Nanohole Arrays for Broad Palettes of Colors

Plasmonics - We investigate aluminum nanopatch/nanohole arrays surrounded by a dielectric material on plastic substrates for large area color printing. In this specific arrangement, metallic...     

Trace fossils from Lower Miocene (Ottnangian) molasse deposits of Upper Austria

Lower Miocene siliciclastic sediments of the Vöckla Schichten and Atzbacher Sande, Austria, contain a shallow-water trace-fossil assemblage of the Cruziana ichnofacies includingSkolithos isp.,Planolites ? beverleyensis, Ophiomorpha annulata, O.nodosa, Rosselia socialis, Cylindrichnus concentricus, Scolicia isp., andBichordites monastiriensis. The ichnogenusRosselia and the ichnospeciesRosselia socialis are revised. Analysis ofScolicia isp. andB. monastiriensis provides new information about their morphology and ichnotaxonomy.